3-methylglutaconic acid has been researched along with Dyskinesia Syndromes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Costeff, H; Elpeleg, ON; Gibson, KM; Joseph, A; Shental, Y; Weitz, R | 1 |
Brismar, J; Gascon, GG; Ozand, PT | 1 |
Apter, N; Böhles, HJ; Costeff, H; Elpeleg, ON; Prialnic, M | 1 |
Al-Essa, M; Al-Shamsan, L; Bakheet, S; Ozand, PT; Patay, Z; Powe, J | 1 |
1 trial(s) available for 3-methylglutaconic acid and Dyskinesia Syndromes
Article | Year |
---|---|
Ineffectiveness of oral coenzyme Q10 supplementation in 3-methylglutaconic aciduria, type 3.
Topics: Administration, Oral; Adolescent; Adult; Child; Coenzymes; Cross-Over Studies; Female; Glutarates; Humans; Male; Movement Disorders; Neuromuscular Diseases; Optic Atrophy; Single-Blind Method; Treatment Failure; Ubiquinone; Visual Acuity | 1998 |
3 other study(ies) available for 3-methylglutaconic acid and Dyskinesia Syndromes
Article | Year |
---|---|
3-Methylglutaconic aciduria in the Iraqi-Jewish 'optic atrophy plus' (Costeff) syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Cognition Disorders; Female; Glutarates; Humans; Iraq; Jews; Male; Meglutol; Movement Disorders; Optic Atrophy; Syndrome | 1994 |
Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations.
Topics: Acidosis; Basal Ganglia; Brain; Child; Child, Preschool; Dystonia; Female; Glutarates; Humans; Infant; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Movement Disorders; Muscle Rigidity; Myoclonus; Necrosis; Propionates; Tomography, X-Ray Computed | 1994 |
18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Topics: Brain; Brain Diseases; Child; Child, Preschool; Fluorodeoxyglucose F18; Glutarates; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Nervous System Diseases; Optic Atrophy; Paraplegia; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |